Featured Research

from universities, journals, and other organizations

A Biomarker To Predict Osteoarthritis

Date:
January 10, 2005
Source:
John Wiley & Sons, Inc.
Summary:
A chronic degenerative joint disease, osteoarthritis (OA) is a common cause of pain and disability among older Americans. OA of the knee affects up to 6 percent of the older population, while OA of the hip affects about another 3 percent. While treatments vary, there is hope that early intervention – before joint destruction can be clearly seen and measured on an X-ray image-will improve outcomes.

A chronic degenerative joint disease, osteoarthritis (OA) is a common cause of pain and disability among older Americans. OA of the knee affects up to 6 percent of the older population, while OA of the hip affects about another 3 percent. While treatments vary, there is hope that early intervention – before joint destruction can be clearly seen and measured on an X-ray image-will improve outcomes.

The need for better ways to assess OA's activity from its onset has led researchers to investigate possible biomarkers, particularly those related to cartilage and bone turnover. A biomarker is substance found in the blood or joint fluid whose levels can be used to assess the presence or activity of a disease. Among likely candidates for a biomarker for OA is hyaluronic acid, also known as hyaluronan or simply HA. HA is a component of connective tissue that is widely distributed throughout the body and plays an important role in joint function. A recent study, published in the January 2005 issue of Arthritis & Rheumatism (http://www.interscience.wiley.com/journal/arthritis), strongly supports the relationship between increased production of HA and increased risk for OA, specifically of the knees and hips, among ethnically diverse men and women.

Led by Drs. Alan L. Elliott and Joanne M. Jordan of the Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, and Dr. Virginia B. Kraus of Duke University Medical Center, the study drew its subjects from a large, local population of participants in the Johnston County Osteoarthritis Project. The study group comprised 753 subjects, including 120 African American men, 245 African American women, 199 Caucasian men, and 189 Caucasian women. The average age of the participants was just shy of 62 years and the mean body mass index was on the heavy side, just over 30. Of the total subjects, 455 had mild to severe knee OA, confirmed by radiographs. 152 of the subjects with knee OA also had hip OA. In 52 of these individuals with OA, the disease had progressed to both knees and both hips.

The research team obtained a blood sample from every participant and analyzed each for its concentration of HA. Across the board, Caucasians had higher serum HA levels than African Americans and men had higher serum HA levels than women. The most compelling differences in HA levels, however, were between the 298 subjects without any radiographic evidence of OA and the 455 OA participants – especially those with two or more joints affected. As the presence and amount of OA involvement increased, so did the HA levels. On average, the concentration of HA was higher in patients with severe knee OA compared to those in the moderate stages of disease, higher in patients with two diseased knees compared to those with a single diseased knee, and higher in patients with hip OA in addition to knee OA compared to those with knee OA alone. When adjusted for ethnicity, sex, age, and BMI, the associations between elevated HA levels and all definitions of OA status remained statistically significant.

Also significantly, researchers found no independent correlations between elevated levels of HA and other adverse health conditions reported by the subjects, including high blood pressure, diabetes, chronic pulmonary disease, persistent liver, kidney, bladder, and prostate problems, and cancer. Only one condition showed a sustained independent relationship with elevated HA after statistical adjustment: gout, which, like OA, is marked by joint inflammation and damage.

"The results of this study suggest that serum HA measurements are useful for assessing overall OA load," Dr Elliott notes. "The lack of independent associations of serum HA levels with several comorbid conditions commonly associated with OA further supports its promise in the study of OA."

###

Article: "Serum Hyaluronan Levels and Radiographic Knee and Hip Osteoarthritis in African Americans and Caucasians in the Johnston County Osteoarthritis Project," Alan L. Elliott, Virginia B. Kraus, Gheorghe Luta, Thomas Stabler, Jordan B. Renner, Janice Woodard, Anca D. Dragomir, Charles G. Helmick, Marc C. Hochberg, and Joanne M. Jordan, Arthritis & Rheumatism, January 2005; 52:1; pp. 105-111.


Story Source:

The above story is based on materials provided by John Wiley & Sons, Inc.. Note: Materials may be edited for content and length.


Cite This Page:

John Wiley & Sons, Inc.. "A Biomarker To Predict Osteoarthritis." ScienceDaily. ScienceDaily, 10 January 2005. <www.sciencedaily.com/releases/2005/01/050110115006.htm>.
John Wiley & Sons, Inc.. (2005, January 10). A Biomarker To Predict Osteoarthritis. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2005/01/050110115006.htm
John Wiley & Sons, Inc.. "A Biomarker To Predict Osteoarthritis." ScienceDaily. www.sciencedaily.com/releases/2005/01/050110115006.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins